Cyclerion Therapeutics

$2.58
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.08 (+3.20%) Today
-$0.00 (-0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell CYCN and other stocks, options, and ETFs commission-free!

About CYCN

Cyclerion Therapeutics, Inc. Common Stock, also called Cyclerion Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for serious and orphan diseases, through the use of soluble guanylate cyclase (sGC) pharmacology.

CEO
Peter M. Hecht
Employees
34
Headquarters
Cambridge, Massachusetts
Founded
2018
Market Cap
94.89M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
292.77K
High Today
$2.61
Low Today
$2.38
Open Price
$2.52
Volume
481.23K
52 Week High
$8.96
52 Week Low
$2.18

CYCN Earnings

-$1.00
-$0.67
-$0.33
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 4, Pre-Market

You May Also Like

ALGT
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure